"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."

During the past decade, Allison Cancer Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 23 clinical trials were completed, i.e. on average, 209.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allison Cancer Center" #1 sponsor was "US Oncology Research" with 11 trials, followed by "Bristol-Myers Squibb" with 5 trials sponsored, "Celgene" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "NSABP Foundation Inc" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allison Cancer Center" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Sanofi" with 3 trials as a collaborator and "ARMO BioSciences" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Allison Cancer Center" are "Breast Cancer" (7 trials), "Metastatic Breast Cancer" (6 trials), "Non-Small Cell Lung Cancer" (4 trials), "Prostate Cancer" (4 trials) and "Carcinoma, Non-Small-Cell Lung" (3 trials). Many other conditions were trialed in "Allison Cancer Center" in a lesser frequency.

Most popular intervention types in "Allison Cancer Center" are "Drug" (44 trials), "Biological" (5 trials), "Other" (5 trials), "Diagnostic Test" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Docetaxel" (5 trials), "Nivolumab" (5 trials), "Paclitaxel" (5 trials) and "docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Allison Cancer Center" are 36 trials for "All" genders, 9 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Allison Cancer Center". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Allison Cancer Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Allison Cancer Center, 2 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".